Alternatively, an inhibitory peptide that disrupts the ORF45-RSK interaction has been developed to inhibit spontaneous and chemical-induced KSHV lytic replication [25], providing a promising peptide agent for controlling KSHV lytic infection. This evidence concerns the gene RPS6KA3 and infection.